179 related articles for article (PubMed ID: 23638194)
21. Trypanosoma cruzi trans-sialidase: enhancement of virulence in a murine model of Chagas' disease.
Chuenkova M; Pereira ME
J Exp Med; 1995 May; 181(5):1693-703. PubMed ID: 7722448
[TBL] [Abstract][Full Text] [Related]
22. Mammalian Target of Rapamycin Inhibition in
Rojas Márquez JD; Ana Y; Baigorrí RE; Stempin CC; Cerban FM
Front Immunol; 2018; 9():313. PubMed ID: 29515594
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of cyclooxygenase-1 and cyclooxygenase-2 impairs Trypanosoma cruzi entry into cardiac cells and promotes differential modulation of the inflammatory response.
Malvezi AD; Panis C; da Silva RV; de Freitas RC; Lovo-Martins MI; Tatakihara VL; Zanluqui NG; Neto EC; Goldenberg S; Bordignon J; Yamada-Ogatta SF; Martins-Pinge MC; Cecchini R; Pinge-Filho P
Antimicrob Agents Chemother; 2014 Oct; 58(10):6157-64. PubMed ID: 25092706
[TBL] [Abstract][Full Text] [Related]
24. Cruzipain and Its Physiological Inhibitor, Chagasin, as a DNA-Based Therapeutic Vaccine Against
Cerny N; Bivona AE; Sanchez Alberti A; Trinitario SN; Morales C; Cardoso Landaburu A; Cazorla SI; Malchiodi EL
Front Immunol; 2020; 11():565142. PubMed ID: 33162979
[TBL] [Abstract][Full Text] [Related]
25. 15-Epi-16-(para-fluorophenoxy)-lipoxin A(4)-methyl ester, a synthetic analogue of 15-epi-lipoxin A(4), is protective in experimental ischemic acute renal failure.
Leonard MO; Hannan K; Burne MJ; Lappin DW; Doran P; Coleman P; Stenson C; Taylor CT; Daniels F; Godson C; Petasis NA; Rabb H; Brady HR
J Am Soc Nephrol; 2002 Jun; 13(6):1657-62. PubMed ID: 12039996
[TBL] [Abstract][Full Text] [Related]
26. The in vivo trypanocidal effect of the diterpene 5-epi-icetexone obtained from Salvia gilliesii.
Lozano E; Strauss M; Spina R; Cifuente D; Tonn C; Rivarola HW; Sosa MA
Parasitol Int; 2016 Feb; 65(1):23-26. PubMed ID: 26341064
[TBL] [Abstract][Full Text] [Related]
27. Trypanosoma cruzi: Inhibition of infection of human monocytes by aspirin.
Carvalho de Freitas R; Lonien SCH; Malvezi AD; Silveira GF; Wowk PF; da Silva RV; Yamauchi LM; Yamada-Ogatta SF; Rizzo LV; Bordignon J; Pinge-Filho P
Exp Parasitol; 2017 Nov; 182():26-33. PubMed ID: 28939444
[TBL] [Abstract][Full Text] [Related]
28. Aspirin prevents atrophy of esophageal nitrergic myenteric neurons in a mouse model of chronic Chagas disease.
Massocatto CL; Moreira NM; Muniz E; Pinge-Filho P; Rossi RM; Araújo EJ; Sant'Ana DM
Dis Esophagus; 2017 Feb; 30(2):1-8. PubMed ID: 26725535
[TBL] [Abstract][Full Text] [Related]
29. Lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 inhibit human neutrophil migration: comparisons between synthetic 15 epimers in chemotaxis and transmigration with microvessel endothelial cells and epithelial cells.
Fierro IM; Colgan SP; Bernasconi G; Petasis NA; Clish CB; Arita M; Serhan CN
J Immunol; 2003 Mar; 170(5):2688-94. PubMed ID: 12594298
[TBL] [Abstract][Full Text] [Related]
30. Effect of acetylsalicylic acid on total myenteric neurons in mice experimentally infected with Trypanosoma cruzi.
Souza ND; Belin BS; Massocatto CL; Araújo SM; Sant'ana DMG; Araújo EJA; P Filho P; Nihei OK; Moreira NM
An Acad Bras Cienc; 2019 May; 91(2):e20180389. PubMed ID: 31141012
[TBL] [Abstract][Full Text] [Related]
31. Aspirin treatment exacerbates oral infections by Trypanosoma cruzi.
Cossentini LA; Da Silva RV; Yamada-Ogatta SF; Yamauchi LM; De Almeida Araújo EJ; Pinge-Filho P
Exp Parasitol; 2016 May; 164():64-70. PubMed ID: 26826555
[TBL] [Abstract][Full Text] [Related]
32. Previously unrecognized vaccine candidates control Trypanosoma cruzi infection and immunopathology in mice.
Bhatia V; Garg NJ
Clin Vaccine Immunol; 2008 Aug; 15(8):1158-64. PubMed ID: 18550728
[TBL] [Abstract][Full Text] [Related]
33. Trypanosoma cruzi: both chemically induced and triatomine-derived metacyclic trypomastigotes cause the same immunological disturbances in the infected mammalian host.
Lopes MF; Cunha JM; Bezerra FL; Gonzalez MS; Gomes JE; Lapa e Silva JR; Garcia ES; Dos Reis GA
Exp Parasitol; 1995 Mar; 80(2):194-204. PubMed ID: 7895831
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of voriconazole in a murine model of acute Trypanosoma cruzi infection.
Gulin JE; Eagleson MA; Postan M; Cutrullis RA; Freilij H; Bournissen FG; Petray PB; Altcheh J
J Antimicrob Chemother; 2013 Apr; 68(4):888-94. PubMed ID: 23212113
[TBL] [Abstract][Full Text] [Related]
35. IL-10 limits parasite burden and protects against fatal myocarditis in a mouse model of Trypanosoma cruzi infection.
Roffê E; Rothfuchs AG; Santiago HC; Marino AP; Ribeiro-Gomes FL; Eckhaus M; Antonelli LR; Murphy PM
J Immunol; 2012 Jan; 188(2):649-60. PubMed ID: 22156594
[TBL] [Abstract][Full Text] [Related]
36. Aspirin-triggered lipoxin induces CB1-dependent catalepsy in mice.
Pamplona FA; Menezes-de-Lima O; Takahashi RN
Neurosci Lett; 2010 Feb; 470(1):33-7. PubMed ID: 20036315
[TBL] [Abstract][Full Text] [Related]
37. Experimental Chagas disease. Innate immune response in Balb/c mice previously vaccinated with Trypanosoma rangeli. I. The macrophage shows immunological memory: Reality or fiction?
Basso B; Marini V
Immunobiology; 2014 Apr; 219(4):275-84. PubMed ID: 24321621
[TBL] [Abstract][Full Text] [Related]
38. The brighter (and evolutionarily older) face of the metabolic syndrome: evidence from Trypanosoma cruzi infection in CD-1 mice.
Brima W; Eden DJ; Mehdi SF; Bravo M; Wiese MM; Stein J; Almonte V; Zhao D; Kurland I; Pessin JE; Zima T; Tanowitz HB; Weiss LM; Roth J; Nagajyothi F
Diabetes Metab Res Rev; 2015 May; 31(4):346-359. PubMed ID: 25613819
[TBL] [Abstract][Full Text] [Related]
39. Effect of a combination DNA vaccine for the prevention and therapy of Trypanosoma cruzi infection in mice: role of CD4+ and CD8+ T cells.
Limon-Flores AY; Cervera-Cetina R; Tzec-Arjona JL; Ek-Macias L; Sánchez-Burgos G; Ramirez-Sierra MJ; Cruz-Chan JV; VanWynsberghe NR; Dumonteil E
Vaccine; 2010 Oct; 28(46):7414-9. PubMed ID: 20850536
[TBL] [Abstract][Full Text] [Related]
40. Clomipramine and Benznidazole Act Synergistically and Ameliorate the Outcome of Experimental Chagas Disease.
García MC; Ponce NE; Sanmarco LM; Manzo RH; Jimenez-Kairuz AF; Aoki MP
Antimicrob Agents Chemother; 2016 Jun; 60(6):3700-8. PubMed ID: 27067322
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
